These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1150 related items for PubMed ID: 22508140

  • 1. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M, Fernández-Reyes MJ, Sánchez R, Guerrero MT, Molina A, Rodríguez MA, Alvarez-Ude F.
    Nefrologia; 2012 May 14; 32(3):300-5. PubMed ID: 22508140
    [Abstract] [Full Text] [Related]

  • 2. Serum uric acid as a marker of all-cause mortality in an elderly patient cohort.
    Heras M, Fernández-Reyes MJ, Sánchez R, Molina Á, Rodríguez A, Álvarez-Ude F.
    Nefrologia; 2012 May 14; 32(1):67-72. PubMed ID: 22294005
    [Abstract] [Full Text] [Related]

  • 3. [Elderly patients with chronic kidney disease: what happens after 24 months of follow-up].
    Heras M, Fernández-Reyes MJ, Guerrero MT, Sánchez R, Muñoz A, Macías MC, Molina A, Prado F, Alvarez-Ude F.
    Nefrologia; 2009 May 14; 29(4):343-9. PubMed ID: 19668307
    [Abstract] [Full Text] [Related]

  • 4. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jun 14; 24(144):487-91. PubMed ID: 18702327
    [Abstract] [Full Text] [Related]

  • 5. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF, McCarthy M, Howse ML, Williams PS.
    Ren Fail; 2007 Jun 14; 29(6):653-9. PubMed ID: 17763158
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL, Polkinghorne KR, Atkins RC, Chadban SJ.
    Am J Kidney Dis; 2010 Apr 14; 55(4):660-70. PubMed ID: 20138414
    [Abstract] [Full Text] [Related]

  • 7. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K.
    Nephrol Dial Transplant; 2010 Jan 14; 25(1):278-82. PubMed ID: 19762604
    [Abstract] [Full Text] [Related]

  • 8. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C, Roderick P, Harris S, Rogerson M.
    Nephrol Dial Transplant; 2006 Aug 14; 21(8):2133-43. PubMed ID: 16644779
    [Abstract] [Full Text] [Related]

  • 9. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul 14; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
    Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD.
    Nephron Clin Pract; 2008 Jul 14; 109(3):c109-18. PubMed ID: 18663322
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 20. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
    Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM.
    Am J Kidney Dis; 2005 Nov 25; 46(5):863-70. PubMed ID: 16253726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.